Why the study?
Does a novel perfusion sleeve reduce ischemia during prolonged balloon angioplasty in patients undergoing PTCA?
Does a novel perfusion sleeve reduce ischemia during prolonged balloon angioplasty in patients undergoing PTCA?
The use of a novel perfusion sleeve during standard PTCA is feasible and significantly reduces the magnitude of ischemia during prolonged balloon inflations.
May support ischemia reduction during prolonged PTCA; hypothesis-generating and requires randomized trials before clinical adoption.
The perfusion sleeve (PS) is an "over-the-balloon" catheter designed to add perfusion capability to standard PTCA catheters. To evaluate the clinical effectiveness of this device, eight patients underwent standard PTCA with the PS retracted in the guide (Inflation 1-Control) and after deployment of the PS (Inflation 3-Control). Between standard inflations the PS was advanced and aligned with the already positioned PTCA balloon which was inflated for up to 15 minutes (Inflation 2-Perfusion). TIMI III flow was present in 5/7 and TIMI II flow in 2/7 patients during Inflation 2-Perfusion. Absolute ST segment shift (mm) on the ECG was significantly less at 3 minutes and prior to balloon deflation with the PS in place (1.0 +/- 1.4 and 1.1 +/- 1.1 mm) compared to Inflation 1-Control and Inflation 3-Control (2.6 +/- 1.3 and 2.3 +/- 0.3 mm) respectively (P < or = 0.05). Use of the PS in conjunction with standard PTCA is feasible, provides perfusion during prolonged balloon inflations and reduces the magnitude of ischemia.
No takes yet. Share an insight, caveat, or question.
Cannan et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: